EUS Guided Tissue Ablation

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 16-006869
    Sponsor Protocol Number: 16-006869

About this study

In patients undergoing endoscopic ultrasound guided tissue ablation (EUS TA) (both prior – Retrospective Component) and future Prospective Component), we aim to determine the:

1.) Safety

2.) Efficacy

3.) Correlate the outcomes with patient, ablation site target, technology, and procedural related factors that may impact these outcomes and serve as surrogate markers of success. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

        Inclusion Criteria:

  • 18 years of age or older

  • Endoscopic ultrasound and tumor ablation performed to evaluate and treat disorders as a part of their standard clinical care independent of this study 

    Exclusion Criteria: 

  • None

 

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Michael Levy, M.D.

Contact us for the latest status

Contact information:

Ferga Gleeson M.B., B.Ch.

(507)266-6931

Gleeson.Ferga@mayo.edu